GYRE Therapeutics (GYRE) executive compensation, 2026 proxy

Ping Zhang, Interim Chief Executive Officer, was paid $4.1M in 2025.

Filed
April 27, 2026
Annual meeting
June 10, 2026
Pay year
2025
Named executives
4
CEO total pay
$4.1M2025
CEO Total Compensation
$4,096,623For Interim CEO Ping Zhang
COO Total Compensation
$5,023,749For Weiguo Ye
CFO Base Salary
$250,000For Ruoyu Chen
Interim CEO Base Salary
$189,777Pro-rated for 2025 service

How Zhang was paid

$4.1M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary5%Option awards93%Non-equity incentive2%All other compensation0%

Named executive officers

ExecutiveTotal
Ping ZhangInterim Chief Executive Officer$4,096,623
Ruoyu ChenChief Financial Officer$285,583
Weiguo YeChief Operating Officer$5,023,749
Han Ying, Ph.D.Senior Vice President, Science and Former Chief Executive Officer$353,315

What changed and why

  • $4.1MPing Zhang joined as Interim Chief Executive Officer on August 5, 2025, receiving total compensation of $4,096,623.
  • $5MWeiguo Ye received total compensation of $5,023,749, which included $4,460,335 in option awards.
  • $286KRuoyu Chen received total compensation of $285,583, with a base salary of $250,000.
  • Han Ying served as former Chief Executive Officer and transitioned to Senior Vice President, Science.
  • Compensation elements for named executive officers consisted of base salary, performance-based bonus, and stock options.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.